United Services Automobile Association Fennec Pharmaceuticals Inc. Transaction History

United Services Automobile Association

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$3.85 - $4.95 $885,434 - $1.14 Million	-229,983 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$3.3 - $5.09 $184,578 - $284,698	55,933 Added 32.14%	229,983 $920,000
Q1 2019 May 13, 2019	BUY	$4.64 - $7.58 $92,150 - $150,538	19,860 Added 12.88%	174,050 $844,000
Q4 2018 Feb 13, 2019	BUY	$5.37 - $8.39 $386,221 - $603,425	71,922 Added 87.42%	154,190 $984,000
Q3 2018 Nov 13, 2018	BUY	$7.84 - $10.83 $211,052 - $291,543	26,920 Added 48.64%	82,268 $675,000
Q2 2018 Aug 10, 2018	BUY	$10.05 - $14.33 $95,475 - $136,135	9,500 Added 20.72%	55,348 $578,000
Q1 2018 May 14, 2018	SELL	$8.26 - $12.1 $57,820 - $84,700	-7,000 Reduced 13.25%	45,848 $554,000
Q4 2017 Feb 14, 2018	BUY	$8.9 - $12.35 $104,201 - $144,593	11,708 Added 28.46%	52,848 $527,000
Q3 2017 Nov 14, 2017	BUY	$11.09 - $12.0 $456,242 - $493,680	41,140	41,140 $456,000

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $157M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.